Stephen Mayo, Ph.D.
DirectoratAllogene Therapeutics· In proxies 2023–2025
Stephen Mayo, Ph.D. sits on 3 public boards.
Boards1
- Allogene TherapeuticsDirector · 2 yr on the boardIndependentAudit, Research and Development—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Allogene TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -77%
- Merck & Co.Public company
- Director? – PresentNo stock prices for these years
- Sarepta Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?